Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varalakshmi Janamanchi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|May 18, 2023
Schnitzler syndromeParvathy Ravi Sankar, Varalakshmi Janamanchi, Jaime Vondenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
Cancer Research|March 26, 2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaTanguy Y Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, et al.
Cancer Research|January 7, 2006
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesotheliomaRamasamy Jagadeeswaran, Patrick C Ma, Tanguy Y Seiwert, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|May 18, 2023
Schnitzler syndromeParvathy Ravi Sankar, Varalakshmi Janamanchi, Jaime Vondenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
c-Met is a potentially new therapeutic target for treatment of human melanomaNeelu Puri, Salman Ahmed, Varalakshmi Janamanchi, et al.
Cancer Research|March 26, 2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaTanguy Y Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, et al.
Cancer Research|January 7, 2006
Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesotheliomaRamasamy Jagadeeswaran, Patrick C Ma, Tanguy Y Seiwert, et al.
Cancer Research|January 4, 2008
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasionRamasamy Jagadeeswaran, Hanna Surawska, Soundararajan Krishnaswamy, et al.
Pageof 1